SAFECODE DRUG TECHNOLOGIES CORP. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
SAFECODE DRUG TECHNOLOGIES CORP. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $2.92 million as of 2013-06-30, per its 10-Q filed 2013-08-13.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2013-08-13
- 2013-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $2.92M.
- 2013-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $2.68M.
- 2012-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $2.12M.
- 2012-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $90.91K.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2013-06-30 | $2.92M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $2.68M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $2.12M 10-Q · filed 2013-08-13 |
| 2012-09-30 | $90.91K 10-Q/A · filed 2012-12-18 |
| 2012-06-30 | $69.90K 10-Q/A · filed 2012-12-18 |
| 2012-03-31 | $54.27K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $53.62K 10-K · filed 2013-03-25 |
| 2010-12-31 | $11.76K 10-K · filed 2012-03-29 |